We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fluor
FLR
$7.29B
| $2.7M | 0.02% |
64,118
+14,680
| +30% | +$609K |
|
502
Acadia Pharmaceuticals
ACAD
$4.25B
| $2.68M | 0.02% |
71,245
+6,600
| +10% | +$215K |
|
503
Kimco Realty
KIM
$17.6B
| $2.68M | 0.02% |
137,247
-8,393
| -6% | -$165K |
|
504
Zimmer Biomet
ZBH
$17.7B
| $2.68M | 0.02% |
23,571
+3,411
| +17% | +$394K |
|
505
Zions Bancorporation
ZION
$10.1B
| $2.68M | 0.02% |
56,764
+6,558
| +13% | +$292K |
|
506
Revvity
RVTY
$12.3B
| $2.66M | 0.02% |
38,527
-1,853
| -5% | -$124K |
|
|
CLVS
507
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.61M | 0.02% |
31,711
+4,914
| +18% | +$390K |
|
508
NiSource
NI
$22.4B
| $2.6M | 0.02% |
101,583
+3,391
| +3% | +$89.2K |
|
|
HES
509
DELISTED
Hess
HES
| $2.58M | 0.02% |
54,906
+9,588
| +21% | +$406K |
|
|
CSRA
510
DELISTED
CSRA Inc.
CSRA
| $2.57M | 0.02% |
79,652
-300
| -0.4% | -$9.67K |
|
|
VAR
511
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.57M | 0.02% |
25,641
+16,690
| +186% | +$1.71M |
|
512
NetApp
NTAP
$32.9B
| $2.56M | 0.02% |
58,541
+5,999
| +11% | +$248K |
|
513
Range Resources
RRC
$9.11B
| $2.53M | 0.02% |
129,307
+87,086
| +206% | +$1.68M |
|
514
Albemarle
ALB
$13.5B
| $2.52M | 0.02% |
18,511
+3,169
| +21% | +$377K |
|
515
Nektar Therapeutics
NKTR
$2.39B
| $2.52M | 0.02% |
7,001
+664
| +10% | +$208K |
|
|
GRMN
516
Garmin
GRMN
$46.9B
| $2.52M | 0.02% |
46,606
-305
| -0.7% | -$15.8K |
|
517
Camden Property Trust
CPT
$11.3B
| $2.51M | 0.02% |
27,476
-1,938
| -7% | -$174K |
|
518
Public Service Enterprise Group
PEG
$39.8B
| $2.51M | 0.02% |
54,320
+7,349
| +16% | +$333K |
|
519
International Paper
IP
$22.3B
| $2.5M | 0.02% |
46,413
+5,394
| +13% | +$284K |
|
520
Cummins
CMI
$91.7B
| $2.49M | 0.02% |
14,841
+2,208
| +17% | +$357K |
|
521
Liberty Global Class A
LBTYA
$3.31B
| $2.48M | 0.02% |
73,184
+4,072
| +6% | +$136K |
|
522
Avery Dennison
AVY
$12.3B
| $2.48M | 0.02% |
25,213
-5,087
| -17% | -$479K |
|
|
EVHC
523
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.46M | 0.02% |
54,616
+31,585
| +137% | +$1.68M |
|
524
Aptiv
APTV
$12B
| $2.44M | 0.02% |
24,835
+3,210
| +15% | +$303K |
|
525
Amphenol
APH
$188B
| $2.42M | 0.02% |
114,224
+15,308
| +15% | +$301K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.